• Denver’s UNDY Run/Walk fast approaching

    June in Colorado is synonymous with fun runs. Many of the 5Ks support good causes…

  • CU Cancer Center consults on king cobra conundrum

      University of Colorado Cancer Center worked with Denver Zoo in an unusual collaboration. Treating…

  • Brigatinib first drug to offer over 1-year control of ALK-positive lung cancer post-crizotinib

    Clinical trial results lead to FDA approval of brigatinib as a second-line therapy for ALK-positive non-small cell lung cancer.

  • New clinical trial framework tests ‘natural’ cures for cancer

    A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to test the ability of grape seed extract to slow the rise of prostate-specific antigen (PSA), a common marker of prostate cancer progression.

  • Healthline names Colorado Cancer Blogs one of 18 “Best Cancer Blogs of the Year”

    ColoradoCancerBlogs.org is honored to be among the 18 blogs chosen by Healthline.com in its list “The Best Cancer Blogs of the Year.”

Patient Care

colon cancer cu cancer center

Hereditary Cancer Clinic helps catch colon cancer early

Colorectal cancer is the fourth most common cancer in the United States and the second…

Read the rest of this entry

Research

Brigatinib first drug to offer over 1-year control of ALK-positive lung cancer post-crizotinib

Clinical trial results lead to FDA approval of brigatinib as a second-line therapy for ALK-positive non-small cell lung cancer.

Read the rest of this entry

prostate cancer cells

Meet the Experts

Rice Bran and Beans – They’re What’s for Dinner

Ryan, Brown and colleagues present their latest findings on cancer-fighting benefits of rice bran and navy beans at the annual American Association of Cancer Research meeting in Washington, D.C.

Read the rest of this entry